相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Leukocyte membrane expansion: a central mechanism for leukocyte extravasation
Sharon Dewitt et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis
Anita S. Galvez et al.
CIRCULATION RESEARCH (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: Evidence from calpastatin-transgenic mice
Julie Peltier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
Steven D. Crowley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Heparin binding EGF is necessary for vasospastic response to endothelin
Dominique Chansel et al.
FASEB JOURNAL (2006)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Physiology of local renin-angiotensin systems
Martin Paul et al.
PHYSIOLOGICAL REVIEWS (2006)
TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease
BH Shah et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review
Daniel A. Duprez
JOURNAL OF HYPERTENSION (2006)
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling
YM Zhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Mechanisms of disease: Calpains and disease
M Zatz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Multifunctionality of PAI-1 in fibrogenesis:: Evidence from obstructive nephropathy in PAI-1-overexpressing mice
S Matsuo et al.
KIDNEY INTERNATIONAL (2005)
Requirement of nuclear factor-κB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo
C Freund et al.
CIRCULATION (2005)
Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains - Evidence from calpastatin mutant mice
J Takano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Calpain inhibition decreases endothelin-1 levels and pulmonary hypertension after cardiopulmonary bypass with deep hypothermic circulatory arrest
JY Duffy et al.
CRITICAL CARE MEDICINE (2005)
Targeted proteolysis sustains calcineurin activation
N Burkard et al.
CIRCULATION (2005)
Regulating cell migration: calpains make the cut
SJ Franco et al.
JOURNAL OF CELL SCIENCE (2005)
Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice
V Gross et al.
JOURNAL OF HYPERTENSION (2004)
Hypertensive myocardial fibrosis and Diastolic dysfunction - Another model of inflammation?
F Kuwahara et al.
HYPERTENSION (2004)
Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation
A Glading et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Fibrotic disease and the TH1/TH2 paradigm
TA Wynn
NATURE REVIEWS IMMUNOLOGY (2004)
Somatostatin binds to murine macrophages through two distinct subsets of receptors
J Perez et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Calpain regulates neutrophil chemotaxis
MA Lokuta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth
BJ Wilkins et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A Ca2+ switch aligns the active site of calpain
T Moldoveanu et al.
CELL (2002)
分享论文
